Search

Displaying results 501 - 510 of 10000 in total
  1. Drug

    6-Methylamino-5-Nitroisocytosine

    go.drugbank.com/drugs/DB03705
    Experimental

    Synonyms: 6-Methylamino-5-Nitroisocytosine
  2. Drug

    Adenosine-5'-(Dithio)Phosphate

    go.drugbank.com/drugs/DB03011
    Experimental

    Synonyms: Adenosine-5'-(Dithio)Phosphate
  3. Drug

    Deoxycytidylyl-3',5'-guanosine

    go.drugbank.com/drugs/DB03326
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSynonyms: Deoxycytidylyl-3',5'-guanosine
  4. Drug

    5-Oxo-L-Norleucine

    go.drugbank.com/drugs/DB04296
    Experimental

    Synonyms: 5-Oxo-L-Norleucine
  5. Drug

    5-PENTYL-2-PHENOXYPHENOL

    go.drugbank.com/drugs/DB07178
    Experimental

    Synonyms: 5-PENTYL-2-PHENOXYPHENOL
  6. Drug

    8-Bromoadenosine-5'-Diphosphate

    go.drugbank.com/drugs/DB04554
    Experimental

    Synonyms: 8-Bromoadenosine-5'-Diphosphate
  7. Drug

    Alpha-Ribazole-5'-Phosphate

    go.drugbank.com/drugs/DB02030
    Experimental

    Synonyms: Alpha-Ribazole-5'-Phosphate
  8. Drug

    Galactose-uridine-5'-diphosphate

    go.drugbank.com/drugs/DB03501
    Experimental

    Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose. … A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism.

    Categories: Heterocyclic Compounds, 1-RingSynonyms: Galactose-uridine-5'-diphosphate, UDP-α-D-galactose
  9. Drug

    Zomepirac

    go.drugbank.com/drugs/DB04828
    ApprovedWithdrawn

    Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.

    Synonyms: 5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acidCategories: Non COX-2 selective NSAIDS, Heterocyclic Compounds, 1-Ring
  10. Drug

    Orforglipron

    go.drugbank.com/drugs/DB18964
    ApprovedInvestigational

    [L56122,L56123] It was the first new molecular entity approved under the Commissioner’s National Priority Voucher (CNPV) pilot program, achieving a regulatory decision just 50 days after filing. … Orforglipron is a first-in-class oral, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist.

    Categories: GLP-1 Agonists, Heterocyclic Compounds, 1-RingSynonyms: 1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3, 3-[(1S,2S)-1-({2-(4-fluoro-3,5-dimethylphenyl)-3-({3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}carbonyl)-5-[(